黑料社

Event

From Estimands to Robust Inference of Treatment Effects in Master Protocol Trials

Wednesday, November 12, 2025 15:30to16:30

Ting Ye, PhD

Assistant Professor, Department of Biostatistics听|
University of Washington

WHEN: Wednesday, November 12, 2025, from 3:30 to 4:30 p.m.
WHERE: Hybrid | 2001 黑料社 College Avenue, Rm 1140;
NOTE:听Ting Ye will be presenting from Seattle

Abstract

A master protocol trial is an innovative clinical trial design that uses a single overarching protocol to evaluate multiple treatments, diseases, or disease subtypes, where participants are often randomized to different subsets of treatment arms based on individual characteristics, enrollment timing, and treatment availability. While offering increased flexibility, this constrained and non-uniform treatment assignment poses inferential challenges, with two fundamental ones being the precise definition of treatment effects and robust, efficient inference on these effects. Such challenges arise primarily because some commonly used analysis approaches may target estimands defined on populations inadvertently depending on randomization ratios or trial operational format, thereby undermining interpretability. This article, for the first time, presents a formal framework for constructing a clinically meaningful estimand with precise specification of the population of interest. Specifically, the proposed entire concurrently eligible (ECE) population not only preserves the integrity of randomized comparisons but also remains invariant to both the randomization ratio and trial operational format. Then, we develop weighting and post-stratification methods to estimate treatment effects under the same minimal assumptions used in traditional randomized trials. We also consider model-assisted covariate adjustment to fully unlock the efficiency potential of master protocol trials while maintaining robustness against model misspecification. The SIMPLIFY trial, a master protocol assessing continuation versus discontinuation of two common therapies in cystic fibrosis, is utilized to further highlight the practical significance of this research. All analyses are conducted using the R package RobinCID..


Speaker Bio

Please visit website:听

Back to top